Search for content, post, videos

US approval for SciBase’s Nevisense

Examin_Arm_Nevisense-melanoma
The US Food and Drug Administration has approved the Scibase Pre-Market Approval (PMA) for its product Nevisense. Nevisense is SciBase's device for the early detection of malignant melanoma. With the approval, SciBase can now market and sell Nevisense in the US.  According to the letter from the
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.